Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis genetics: leaving no stone unturned.

J R Oksenberg1, L F Barcellos

  • 1Department of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA 94143, USA. oksen@itsa.ucsf.edu

Genes and Immunity
|June 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breastfeeding is associated with reduced risk of multiple sclerosis in males, predominantly among HLA-DRB1*15:01 carriers.

Multiple sclerosis journal - experimental, translational and clinical·2020
Same author

The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.

Multiple sclerosis (Houndmills, Basingstoke, England)·2019
Same author

Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation.

Genes and immunity·2016
Same author

High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.

Journal of neurology, neurosurgery, and psychiatry·2016
Same author

The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.

Genes and immunity·2016
Same author

Genetic associations with brain cortical thickness in multiple sclerosis.

Genes, brain, and behavior·2015
Same journal

Genetic regulation of platelet-derived BDNF by rs11030119: discrepancy between circulating levels and hemostatic function.

Genes and immunity·2026
Same journal

Neutrophil extracellular traps formation driven by novel ELANE mutations in cyclic neutropenia patients.

Genes and immunity·2026
Same journal

Immunogenetics in psoriasis: towards personalised diagnosis and treatment strategies.

Genes and immunity·2026
Same journal

Hyperactivation of the cGAS-STING pathway promotes liver inflammation in Down syndrome.

Genes and immunity·2026
Same journal

Immunological and prognostic impact of NRF2 in high grade serous ovarian cancer.

Genes and immunity·2026
Same journal

RASSF2 promoter hypermethylation determines malignant and microenvironmental features in lung cancer.

Genes and immunity·2026
See all related articles

Genetic factors significantly influence multiple sclerosis (MS) risk, progression, and treatment response. Understanding gene interactions and environmental factors is key to developing new therapies for MS.

Area of Science:

  • Neuroimmunology
  • Genetics of Neurological Disorders
  • Molecular Medicine

Background:

  • Epidemiologic and molecular data strongly suggest a primary genetic role in multiple sclerosis (MS) etiology.
  • The genetic contribution to MS is complex, involving allelic variants in multiple genes with incomplete penetrance and moderate individual effects.
  • Locus heterogeneity is probable, meaning different genes influence susceptibility and pathogenesis in distinct individuals.

Purpose of the Study:

  • To elucidate the genetic underpinnings of multiple sclerosis (MS) susceptibility and pathogenesis.
  • To establish a framework for understanding the mechanisms of current MS therapies.
  • To provide a rationale for developing novel curative strategies for MS.

Main Methods:

  • Integration of genomic, transcriptional, proteomic, and phenotypic data.

Related Experiment Videos

  • Utilizing novel analytical algorithms for data analysis.
  • Studying well-controlled patient cohorts.

    • Main Results:

    • Genes play a primary role in MS risk, disease progression, and therapeutic response.
    • Genetic influences are modulated by epistatic interactions, post-transcriptional regulation, and environmental factors.
    • Locus heterogeneity contributes to the variable presentation and susceptibility to MS.

    Conclusions:

    • A comprehensive understanding of MS pathogenesis requires integrating multi-omics data.
    • This integrated approach will define a conceptual model for MS and guide the development of new therapeutic strategies.
    • Targeting genetic and molecular pathways holds promise for future MS treatments.